On March 15, 2026, Henan’s first humanoid robot 4S store officially opened in Zhengzhou. Since its soft launch at the end of January this year,

In the world of non-standard automation, where every production line has unique challenges—tight spaces, complex part geometries, and diverse process requirements—Epson 6-axis robots stand out

In the highly regulated medical device industry, the synergy between injection molding and automated assembly defines production efficiency, quality consistency, and regulatory compliance. A syringe

In the world of non-standard automation, one robot brand stands above the rest for precision, reliability, and ease of integration: Epson Robots. For over 40

In the medical device industry, where precision, compliance, and efficiency are non-negotiable, the right assembly equipment can make or break production success. Medical device assembly

In the cosmetic manufacturing sector, the lip gloss applicator (brush or wand) is a critical component that directly impacts user experience and product appeal. For

From laboratory prototypes to gradual commercial mass production, humanoid robots are emerging as a core track in global high-end manufacturing and artificial intelligence, sparking a

In the fast-paced cosmetic industry, efficient and high-quality production is the key to gaining a competitive edge. For lip gloss manufacturers, the assembly of lip

As an important milestone in modern manufacturing, 5-axis machining technology has revolutionized the production of complex parts with its outstanding performance and versatile processing capabilities.

As a core non-traditional machining technology in precision manufacturing, Electrical Discharge Machining (EDM) not only features unique processing characteristics but also demonstrates irreplaceable advantages in

According to media reports on March 12, China has achieved a major breakthrough in hydrogen energy storage and transportation. A large scale solid state hydrogen

On March 10, Orbbec Inc. (Stock Code: 688322.SH) announced that its application for the issuance of A-shares to specific targets in 2025 had been approved